Voorbeelden van het gebruik van Ml docetaxel in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
One vial contains 20 mg/0.5 ml docetaxel.
The reconstituted solution contains~ 24 mg/ml docetaxel, corresponding with an extractable volume of approximately.
a concentration of 0.74 mg/ml docetaxel is not exceeded.
The reconstituted solution contains 24 mg/ml docetaxel and should be used immediately after preparation.
yellow to brown- yellow solution containing 40 mg/ ml docetaxel(anhydrous) in polysorbate 80.
The volume of concentrate(24 mg/ml docetaxel) corresponding to the required dose(mg)
The viscous solution contains 40 mg/ml docetaxel anhydrous.
The addition of the entire contents of the solvent vial to the contents of the Docetaxel Winthrop 20 mg vial ensures a premix concentration of 10 mg/ ml docetaxel.
For example, a dose of 140 mg docetaxel would require 7 ml docetaxel concentrate for solution for infusion.
The addition of the entire contents of the solvent vial to the contents of the Docetaxel Teva Pharma 20mg vial ensures a premix concentration of 10 mg/ml docetaxel.
aseptically withdraw the corresponding premix volume containing 10 mg/ ml docetaxel from the appropriate number of premix vials using graduated syringes fitted with a needle.
The addition of the entire contents of the solvent vial to the contents of the docetaxel 80 mg concentrate for solution for infusion vial ensures a premix concentration of 10 mg/ml docetaxel.
patient expressed in mg, aseptically withdraw the corresponding volume of concentrate for solution containing 20 mg/ml docetaxel from the appropriate number of vials using graduated syringes fitted with a 21G needle.
The addition of the entire contents of the solvent vial to the contents of the Docetaxel Winthrop 20 mg concentrate for solution for infusion vial ensures a premix concentration of 10 mg/ ml docetaxel.
For example, a dose of 140 mg docetaxel would require 14 ml docetaxel premix solution.
yellow to brown- yellow solution containing 40 mg/ml docetaxel(anhydrous) in polysorbate 80 and citric acid.
a concentration of 0.74 mg/ml docetaxel is not exceeded in the final solution for infusion.
This overfill ensures that after dilution with the entire contents of the accompanying solvent for docetaxel vial, there is a minimal extractable premix volume of 2 ml containing 10 mg/ml docetaxel which corresponds to the labelled amount of 20 mg per vial.
This overfill ensures that after dilution with the entire contents of the accompanying solvent for docetaxel vial, there is a minimal extractable premix volume of 2 ml containing 10 mg/ml docetaxel which corresponds to the labelled amount of 20 mg per vial.
there is a minimal extractable premix volume of 2 ml containing 10 mg/ ml docetaxel which corresponds to the labelled amount of 20 mg per vial.
Preparation of the TAXOTERE premix solution 10 mg docetaxel/ml.
Preparation of the TAXOTERE premix solution 10 mg docetaxel/ ml.
Each ml of docetaxel solution contains 40 mg of docetaxel anhydrous.
Preparation of the Docetaxel Teva premix solution 10 mg docetaxel/ml.
Preparation of the Docetaxel Winthrop premix solution 10 mg docetaxel/ ml.
